Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CASP2 | P42575 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17347892 | 0.92 | EPHX2 (0.53) | PRMT1EPHX2MEN1MAPTKMT2A | |
| SCHEMBL1401106 | 0.83 | — | — | |
| SCHEMBL23728799 | 0.82 | EPHX2 (0.39) | PRMT1EPHX2MEN1MAPTKMT2A | |
| SCHEMBL17760454 | 0.81 | PRMT1 (0.55) | PRMT1EPHX2ADRA1AKDM4E | |
| SCHEMBL17761130 | 0.81 | PRMT1 (0.55) | PRMT1EPHX2ADRA1AKDM4E | |
| SCHEMBL2806091 | 0.81 | ATM (0.57) | PRMT1EPHX2MEN1MAPTKMT2A | |
| SCHEMBL16710251 | 0.80 | FAAH (0.43) | PRMT1EPHX2MEN1MAPTKMT2A | |
| SCHEMBL15399971 | 0.79 | TSHR (0.65) | PRMT1EPHX2MEN1MAPTKMT2A | |
| SCHEMBL9717385 | 0.79 | TSHR (0.59) | PRMT1EPHX2MEN1MAPTKMT2A | |
| SCHEMBL2811862 | 0.79 | PRMT1 (0.60) | PRMT1EPHX2MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | SRMS, PTMS, QPCTL | PRMT1 88/4885EPHX2 450/4885MEN1 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.